Prf Technologies Ltd. (PRFX) — 6-K Filings

6-K Filings (50)

• PRF Technologies Ltd. Files 6-K Report — Apr 28, 2026 Risk: low
  PRF Technologies Ltd. filed a Form 6-K on April 28, 2026, reporting information as a foreign issuer. The filing includes a primary 6-K document, an exhibit (EX-
• PRF Technologies Ltd. Files Form 6-K — Mar 27, 2026 Risk: low
  PRF Technologies Ltd. filed a Form 6-K on March 27, 2026. This report, filed by a foreign issuer, contains information typically submitted periodically to the S
• 6-K Filing — Dec 30, 2025
• PainReform's LayerBio Platform Accommodates Multiple Drugs — Dec 10, 2025 Risk: low
  On December 10, 2025, PainReform Ltd. announced that its LayerBio drop-less sustained-release ocular platform has demonstrated the ability to accommodate multip
• PainReform Starts Phase II Trial for OcuRing™-K — Dec 2, 2025 Risk: medium
  On December 2, 2025, PainReform Ltd. announced the commencement of its Phase II trial for OcuRing™-K, a drop-less sustained-release ocular therapy developed by
• PainReform Ltd. Sets Annual Shareholder Meeting for Dec 30 — Nov 25, 2025 Risk: low
  PainReform Ltd. announced on November 25, 2025, that its Annual General Meeting of Shareholders will take place on December 30, 2025, at 3:00 p.m. Israel time.
• PainReform's DeepSolar Advances AI Reporting Engine — Nov 12, 2025 Risk: low
  On November 12, 2025, PainReform Ltd. announced that its subsidiary, DeepSolar, is advancing the development of its AI-driven automated reporting engine for sol
• PainReform's DeepSolar Featured, Progressing Towards Pilots — Nov 5, 2025 Risk: medium
  PainReform Ltd. announced on November 5, 2025, that its DeepSolar product is being developed within the NVIDIA Connect Program, with a focus on "DeepSolar Predi
• PainReform Ltd. Files 6-K Report — Oct 1, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on October 1, 2025, reporting for the period ending June 30, 2025. This filing incorporates by reference information into sever
• PainReform Ltd. Joins NVIDIA Connect Program — Aug 19, 2025 Risk: medium
  On August 19, 2025, PainReform Ltd. announced its acceptance into the NVIDIA Connect Program, a collaboration with DeepSolar. This program aims to leverage NVID
• PainReform Ltd. Files 6-K, Incorporates Press Release — Aug 13, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on August 13, 2025, to incorporate by reference a press release into its existing Registration Statements on Form S-8 and Form
• PainReform Ltd. Files 6-K, Incorporates into Registration Statements — Jul 10, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on July 10, 2025, to report information for the month of July 2025. This filing incorporates by reference into several of the c
• PainReform Launches AI Pilot with Econergy for Solar Project — May 7, 2025 Risk: low
  On May 7, 2025, PainReform Ltd. announced a strategic Artificial Intelligence pilot program with Econergy. This initiative will utilize PainReform's proprietary
• PainReform Ltd. 6-K Filing Incorporated into Registration Statements — Apr 17, 2025 Risk: low
  PainReform Ltd. is incorporating by reference its Form 6-K filing into several of its existing registration statements on Form S-8 and Form F-3. This means the
• PainReform Ltd. Files April 2025 Report on Form 6-K — Apr 11, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on April 11, 2025, to report its activities for the month of April 2025. This report is incorporated by reference into several
• PainReform Ltd. Shareholder Meeting Approves All Proposals — Apr 10, 2025 Risk: low
  On April 10, 2025, PainReform Ltd. held an Extraordinary General Meeting of Shareholders where all four proposals presented were approved. These proposals were
• PainReform Adjourns Shareholder Meeting Due to Lack of Quorum — Apr 3, 2025 Risk: medium
  PainReform Ltd. convened an Extraordinary General Meeting of Shareholders on April 3, 2025, but it was adjourned for one week due to a lack of quorum. The meeti
• PainReform Acquires AI Solar Analytics Platform DeepSolar — Mar 5, 2025 Risk: medium
  On March 5, 2025, PainReform Ltd. announced the successful closing of its acquisition of DeepSolar, an AI-driven solar analytics platform. DeepSolar was acquire
• PainReform Ltd. Schedules Extraordinary Shareholder Meeting — Feb 27, 2025 Risk: low
  PainReform Ltd. announced on February 27, 2025, that it will hold an Extraordinary General Meeting of Shareholders on April 3, 2025, at 3:00 p.m. (Israel time).
• PainReform Ltd. Files 6-K, Incorporates by Reference — Feb 26, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on February 26, 2025, to incorporate by reference into its existing registration statements on Form S-8 and Form F-3. The filin
• PainReform Ltd. 6-K Filing Incorporates into Registration Statements — Feb 18, 2025 Risk: low
  PainReform Ltd. filed a Form 6-K on February 18, 2025, to report information for the month of February 2025. This report is incorporated by reference into sever
• PainReform Ltd. (PRFX) Warrants Exercised in December — Jan 2, 2025 Risk: low
  PainReform Ltd. (PRFX) filed a Form 6-K on January 2, 2025, to incorporate by reference its filings into existing registration statements. During December 2024,
• PainReform Ltd. Files 6-K, Incorporates Press Release — Dec 27, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on December 27, 2024, to incorporate by reference a press release into its existing SEC registration statements. This filing do
• PainReform Ltd. Files 6-K for Registration Statement Incorporation — Dec 4, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on December 4, 2024, to incorporate by reference into its existing registration statements. This filing includes information re
• PainReform Ltd. Files 6-K, Incorporates Press Release — Nov 20, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on November 20, 2024, to report information for the month of November 2024. This filing incorporates by reference a press relea
• PainReform Ltd. Announces 1-for-10 Reverse Share Split — Nov 18, 2024 Risk: medium
  PainReform Ltd. announced on November 18, 2024, that it will implement a reverse share split of its ordinary shares after market close on Wednesday, November 20
• PainReform Ltd. Shareholders Approve All Proposals at EGM — Nov 12, 2024 Risk: low
  On November 11, 2024, PainReform Ltd. held an Extraordinary General Meeting of Shareholders where all three proposals presented were approved. These proposals w
• PainReform Receives Nasdaq Listing Qualifications Letter — Nov 7, 2024 Risk: medium
  On November 7, 2024, PainReform Ltd. announced it received a letter from Nasdaq Listing Qualifications. The company is providing this update via a Form 6-K fili
• PainReform Adjourns Shareholder Meeting Due to Lack of Quorum — Nov 4, 2024 Risk: medium
  PainReform Ltd. held an Extraordinary General Meeting of Shareholders on November 4, 2024, but it was adjourned for one week due to a lack of quorum. The meetin
• PainReform Ltd. Files 6-K for Registration Statement Updates — Oct 16, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on October 16, 2024, to incorporate by reference this report into its existing Registration Statements on Form S-8 and Form F-3
• PainReform Ltd. Schedules Extraordinary General Meeting — Oct 10, 2024 Risk: low
  PainReform Ltd. announced on October 10, 2024, that it will hold an Extraordinary General Meeting of Shareholders on November 4, 2024, at 3:00 p.m. Israel time.
• PainReform Ltd. Holds Annual Shareholder Meeting — Oct 7, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on October 7, 2024, to incorporate by reference into its existing registration statements. This filing relates to the company's
• PainReform Ltd. Files 6-K, Incorporates into Registration Statements — Sep 30, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on September 30, 2024, to report information for the month of September 2024. This filing is incorporated by reference into sev
• PainReform Ltd. Files 6-K for September 2024 — Sep 11, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on September 11, 2024, to incorporate by reference into its existing registration statements on Form S-8 and Form F-3. This fil
• PainReform Ltd. Files 6-K, Incorporates Press Release — Sep 10, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on September 10, 2024, to report information as a foreign private issuer. This filing incorporates by reference a press release
• PainReform Ltd. Announces Reverse Share Split — Sep 4, 2024 Risk: medium
  PainReform Ltd. announced on September 4, 2024, that it will implement a reverse share split of its ordinary shares after market close on Friday, September 6, 2
• PainReform Ltd. Sets Annual Shareholder Meeting for Sept 30 — Aug 26, 2024 Risk: low
  PainReform Ltd. announced on August 26, 2024, that its Annual General Meeting of Shareholders will be held on September 30, 2024, at 3:00 p.m. Israel time. The
• PainReform Ltd. Files Q2 2024 Financial Results — Aug 15, 2024 Risk: low
  On August 15, 2024, PainReform Ltd. announced its financial results for the second quarter ended June 30, 2024. The company is a foreign private issuer based in
• PainReform Ltd. Holds Shareholder Meeting, Filing Incorporated — Aug 13, 2024 Risk: low
  On August 13, 2024, PainReform Ltd. held an Extraordinary General Meeting of Shareholders. This Form 6-K filing is incorporated by reference into the company's
• PainReform Ltd. Schedules Extraordinary Shareholder Meeting — Jul 9, 2024 Risk: low
  PainReform Ltd. announced on July 9, 2024, that it will convene an Extraordinary General Meeting of Shareholders on August 13, 2024, at 3:00 p.m. (Israel time).
• PainReform Ltd. Files 6-K, Incorporates Press Release — Jun 26, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on June 26, 2024, to incorporate by reference a press release into its existing registration statements. This filing does not c
• PainReform Receives Nasdaq Non-Compliance Letter — May 31, 2024 Risk: medium
  On May 31, 2024, PainReform Ltd. announced it received a letter from Nasdaq Listing Qualifications. The company is required to submit a plan to regain complianc
• PainReform Ltd. Files Q1 2024 Financial Results — May 15, 2024 Risk: low
  PainReform Ltd. announced its unaudited condensed financial statements and operating/financial review as of March 31, 2024, for the three months then ended. Thi
• PainReform Ltd. Announces Public Offering of Shares and Warrants — Apr 17, 2024 Risk: medium
  On April 15, 2024, PainReform Ltd. entered into a definitive securities purchase agreement for a public offering. The offering involves the sale of 447,500 ordi
• PainReform Ltd. Files 6-K, Incorporates Press Release — Apr 16, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on April 16, 2024, to report information for the month of April 2024. This filing incorporates by reference the company's press
• PainReform Ltd. Files 6-K, Incorporates Press Release — Apr 9, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on April 9, 2024, to report information as a foreign private issuer. The filing incorporates by reference a press release into
• PainReform Ltd. Files 6-K, Incorporates into S-8/F-3 Filings — Apr 8, 2024 Risk: low
  On April 8, 2024, PainReform Ltd. held an Extraordinary General Meeting of Shareholders. This Form 6-K filing is incorporated by reference into several of the c
• PainReform Ltd. Files 6-K, Incorporates Press Release — Apr 2, 2024 Risk: low
  PainReform Ltd. filed a Form 6-K on April 2, 2024, to report information for the month of April 2024. The filing incorporates by reference a press release attac
• PainReform Ltd. Schedules Extraordinary General Meeting — Mar 7, 2024 Risk: low
  PainReform Ltd. announced on March 7, 2024, that it will hold an Extraordinary General Meeting of Shareholders on April 8, 2024, at 3:00 p.m. Israel time. The m
• PainReform Ltd. Issues Year-End Business Update — Mar 1, 2024 Risk: low
  On March 1, 2024, PainReform Ltd. issued a press release providing a year-end business update. The filing incorporates this press release as Exhibit 99.1. The c

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX